Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma [Phase 2]
A Phase 2 trial of paclitaxel plus bevacizumab for metastatic or unresectable angiosarcoma has been terminated, with results posted in March…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating HSV-1716 in patients with non-CNS solid tumors, including rhabdomy…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Use of Propranolol Hydrochloride in the Treatment of Metastatic STS [Phase 2]
A Phase 2 trial at Ain Shams University is studying propranolol hydrochloride for metastatic soft tissue sarcoma; the current status is UNKN…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma [Phase 2]
Phase 2 trial results for GPX-150 in soft tissue sarcoma have been completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and cetuximab in patients with advanced solid tumors across multiple cancer types; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: 18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating PET/CT using 18F-fluoromisonidazole and 18F-fludeoxyglucose in soft tissue sarcoma was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial of ENMD-2076 in advanced/metastatic soft tissue sarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma [Phase 2]
Phase 2 trial results of palbociclib in patients with advanced or metastatic liposarcoma were posted, detailing outcomes from the study.
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma [Phase 2]
Phase II trial of nivolumab plus ipilimumab in non-resectable soft tissue and bone sarcomas, with exploration across several sarcoma subtype…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated…
-
CLINICAL_TRIALS withdrawal · 2017-10-10Clinical Trial Update: A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment
This clinical trial update states that the NCT00210665 study of trabectedin for locally advanced or metastatic soft tissue sarcoma is no lon…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma [Phase 3]
A Phase 3 clinical trial assessing observation, radiation therapy, chemotherapy, and/or surgery in young patients with soft tissue sarcoma h…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
This entry reports the completion of a dose-escalation Phase 1/2 trial of evofosfamide (TH-302) in combination with doxorubicin for soft tis…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma [Phase 1]
Phase 1 safety trial evaluating preoperative sunitinib with radiation in soft tissue sarcoma has completed.
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas [Phase 2]
A Phase 2 study evaluating nivolumab with or without pazopanib in metastatic or unresectable soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial comparing two first-line treatments for elderly patients with metastatic or advanced soft tissue sarcoma has completed. The …
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma [Phase 2]
A Phase 2 trial evaluated temozolomide in combination with cixutumumab and chemotherapy for metastatic rhabdomyosarcoma; the study has compl…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma [Phase 3]
A Phase 3 clinical trial evaluating the combination of chemotherapy and radiation therapy in newly diagnosed rhabdomyosarcoma patients has c…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg [Phase 2]
Phase 2 trial evaluating image-guided radiation therapy for primary soft tissue sarcoma of the shoulder, arm, hip, or leg; results posted af…
-
FDA approval · 2017-05-31FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) submitted by Novartis Pharmaceuticals Corporation. The ap…
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study. [Phase 2]
A Phase 2, single-arm trial evaluating apatinib as second-line therapy for advanced osteosarcoma and soft tissue sarcomas; the status is cur…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy [Phase 2]
Phase 2 clinical trial update of apatinib mesylate for adult soft tissue sarcoma after chemotherapy failure; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bevacizumab and Radiation Therapy for Sarcomas [Phase 2]
Phase 2 trial evaluating bevacizumab with radiation therapy in soft tissue sarcomas completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
This ClinicalTrials.gov update reports on a completed pediatric cancer trial evaluating dactinomycin and vincristine.